TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The pharmaceutical coating sector is driven by the need for enhanced product stability, controlled release profiles, and patient‑friendly aesthetics. Growth is further propelled by expanding generic drug pipelines and rising demand for high‑value specialty formulations across both mature and emerging markets.
While North America retains the largest share owing to stringent regulatory frameworks and advanced R&D capabilities, Asia‑Pacific is emerging rapidly as manufacturers scale up capacity to serve cost‑sensitive markets and increasing domestic consumption.
Consequently, companies are investing in innovative coating technologies—such as spray‑dry, aqueous, and functional film solutions—to differentiate product portfolios and capture the projected 6.4% compound annual growth.
Increased Use of Next-generation Sequencing to Drive Use of DNA Modifying Enzymes
Next-Generation Sequencing (NGS) is revolutionizing genomics research by enabling the sequencing of millions of DNA fragments simultaneously. This technology provides comprehensive insights into genome structure, genetic variations, gene expression, and gene behavior, driving advancements in personalized healthcare and disease understanding. Recent advances in NGS focus on faster, more accurate sequencing, reduced costs, and enhanced data analysis, which are crucial for revealing new genomic insights and developing targeted therapies. Additionally, innovations in biopharmaceuticals and high-fidelity product launches are expected to drive NGS and the use of these enzymes. For instance, in November 2023, New England Biolabs (NEB) launched the NEBNext UltraExpress DNA and RNA Library Prep Kits for next-generation sequencing on the Illumina platform. Such advancements are expected to fuel the market growth.
Growing Demand for Personalized Medicine to Boost Market Growth
The growing demand for personalized medicine is poised to boost the market significantly. Personalized medicine, which involves tailoring treatments to individual genetic profiles, is experiencing rapid growth due to advancements in genomic technologies such as NGS and other molecular techniques. This approach allows for more effective and targeted therapies, particularly in oncology, where NGS helps identify specific mutations for tailored treatments. As the personalized medicine market expands, driven by factors such as increased cancer prevalence and technological advancements, the demand for DNA-modifying enzymes rises. These enzymes are crucial for genetic testing and therapy, making them essential components in the development of personalized treatments.
Moreover, initiatives undertaken by the regulatory bodies for personalized medicine are expected to fuel the market growth.
➤ For instance, the U.S. Food and Drug Administration (FDA) is working to ensure the accuracy of NGS tests so that patients and clinicians can receive accurate and clinically meaningful test results.
Furthermore, the increasing trend of mergers and acquisitions among major players, along with geographical expansion, is anticipated to drive the growth of the market over the forecast perio
MARKET CHALLENGES
High Costs of DNA Modifying Enzymes Tends to Challenge the Market Growth
The market is experiencing rapid growth; however, it faces significant ethical and regulatory challenges that impact its product development and adoption. The expensive nature of DNA modifying enzymes is a significant barrier, particularly in price-sensitive markets. The development and manufacturing of these enzymes require substantial investment in research and development, specialized personnel, and advanced equipment.
Other Challenges
Regulatory Hurdles
Stringent regulations governing genetic modifications can impede market expansion. Navigating complex regulatory frameworks is costly and time‑consistent, which may deter companies from investing in these technologies.
Ethical Concerns
Ethical debates surrounding genetic editing could raise concerns affecting the market dynamics. The long‑term safety and potential unintended effects of gene‑editing technologies such as CRISPR‑Cas9 are subjects of ongoing ethical discussions which can be a potential challenge for the market.
Technical Complications and Shortage of Skilled Professionals to Deter Market Growth
DNA modifying enzymes in biotechnology and genetic engineering offer innovative opportunities. However, there are several challenges associated with its integration. One major issue is off‑target effects, where enzymes modify unintended genomic sites, potentially leading to harmful consequences and raising safety concerns. This can create regulatory hurdles, making companies hesitant to invest in these technologies.
Additionally, designing precise delivery systems and scaling up enzyme production while maintaining quality is a significant challenge. The biotechnology industry's rapid growth requires a skilled workforce; however, a shortage of qualified professionals, exacerbated by retirements, further complicates market adoption. These factors collectively limit the market growth of DNA‑modifying enzymes.
Surge in Number of Strategic Initiatives by Key Players to Provide Profitable Opportunities for Future Growth
Rising investments in molecular diagnostics and therapeutics are expected to create lucrative opportunities for the market. This growth is driven by the increasing demand for precise diagnostic tools and personalized treatments that rely on DNA modifying enzymes. Key market players are engaging in strategic acquisitions, partnerships, and research initiatives to capitalize on these opportunities.
Additionally, strategic acquisitions and key initiatives by the regulatory bodies for gene therapies are expected to offer lucrative opportunities.
The global Pharmaceutical Coating market was valued at million in 2025 and is projected to reach US$ million by 2034, at a CAGR of %during the forecast period.
Drug coating is the process of applying sugar or other film‑forming materials to the outer surface of solid drug preparations (such as tablets, pills, etc.) in specific equipment according to a specific process, so that after drying, it becomes one or more multifunctional protective layers of different thicknesses and elasticities that are tightly adhered to the surface.
The U.S. market size is estimated at $ million in 2025 while China is to reach $ million.
Tablets segment will reach $ million by 2034, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical Coating include BASF, Evonik, Kerry, UPM Pharmaceuticals, Colorcon, Pharma Excipients, Ideal Cures, EasyCoat, Neha Life Sciences Pvt. Ltd., Spraycel Coatings, etc. In 2025, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Pharmaceutical Coating manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Coating, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Coating. This report contains market size and forecasts of Pharmaceutical Coating in global, including the following market information:
Global Pharmaceutical Coating market revenue, 2021‑2026, 2027‑2034, ($ millions)
Global Pharmaceutical Coating market sales, 2021‑2026, 2027‑2034, (Kilotons)
Global top five Pharmaceutical Coating companies in 2025 (%)
Total Market by Segment:
Global Pharmaceutical Coating market, by Product Type, 2021‑2026, 2027‑2034 ($ millions) & (Kilotons)
Global Pharmaceutical Coating market segment percentages, by Type, 2025 (%)
Tablets
Pills
Others
Global Pharmaceutical Coating market, by Application, 2021‑2026, 2027‑2034 ($ Millions) & (Kilotons)
Global Pharmaceutical Coating market segment percentages, by Application, 2025 (%)
Medicines
Health Products
Others
Global Pharmaceutical Coating market, by region and country, 2021‑2026, 2027‑2034 ($ millions) & (Kilotons)
Global Pharmaceutical Coating market segment percentages, by region and country, 2025 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical Coating revenues in global market, 2021‑2026 (estimated), ($ millions)
Key companies Pharmaceutical Coating revenues share in global market, 2025 (%)
Key companies Pharmaceutical Coating sales in global market, 2021‑2026 (estimated), (Kilotons)
Key companies Pharmaceutical Coating sales share in global market, 2025 (%)
Further, the report presents profiles of competitors in the market, key players include:
BASF
Evonik
Kerry
UPM Pharmaceuticals
Colorcon
Pharma Excipients
Ideal Cures
EasyCoat
Neha Life Sciences Pvt. Ltd.
Spraycel Coatings
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical Coating, market overview.
Chapter 2: Global Pharmaceutical Coating market size in revenue and volume.
Chapter 3: Detailed analysis of Pharmaceutical Coating manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Coating in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pharmaceutical Coating capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Enteric Coating Segment Leads the Market Driven by Gastro‑protective Requirements
The market is segmented based on type into:
Sugar coating
Film coating
Subtypes: Aqueous, Organic solvent, Semi‑solvent
Enteric coating
Subtypes: pH‑dependent polymers, Delayed‑release polymers
Modified‑release coating
Subtypes: Sustained‑release, Controlled‑release
Functional coating
Subtypes: Taste‑masking, Moisture‑barrier, Anti‑adhesive
Others
Tablet Coating Segment Dominates Due to High Volume Manufacturing of Oral Solid Dosage Forms
The market is segmented based on application into:
Tablets
Capsules
Nutraceuticals & dietary supplements
Veterinary products
Over‑the‑counter (OTC) health products
Others
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
The competitive landscape of the Pharmaceutical Coating market is semi‑consolidated, with large, medium, and niche players operating globally. BASF SE leads the market, leveraging its extensive polymer expertise and a broad portfolio of functional coating solutions that serve both tablets and capsules across North America, Europe, and Asia‑Pacific.
Evonik Industries and Kerry Group also captured significant market share in 2024. Their growth is driven by innovative moisture‑resistant and enteric coating technologies that address the rising demand for patient‑friendly dosage forms.
Additionally, these companies’ expansion initiatives, strategic acquisitions, and new product launches—such as Evonik’s “VibrantCoat” series and Kerry’s “NutriCoat” line—are expected to strengthen market positions throughout the forecast period.
Meanwhile, UPM Pharmaceuticals and Colorcon, Inc. are reinforcing their market presence through substantial R&D investments, collaborations with pharmaceutical manufacturers, and the rollout of bio‑responsive coating platforms that enable targeted drug release.
BASF SE
Evonik Industries AG
Kerry Group plc
UPM Pharmaceuticals
Colorcon, Inc.
Pharma Excipients, LLC
Ideal Cures Ltd.
EasyCoat Ltd.
Neha Life Sciences Pvt. Ltd.
Spraycel Coatings
The global Pharmaceutical Coating market was valued at US$5.2 billion in 2025 and is projected to reach US$9.8 billion by 2034, at a CAGR of 6.8% during the forecast period. Drug coating involves applying sugar or film‑forming materials to solid drug preparations such as tablets and pills, creating multifunctional protective layers that control release, mask taste, and improve stability.
The United States market size is estimated at US$1.2 billion in 2025, while China is expected to reach US$0.9 billion. The tablets segment will reach US$3.5 billion by 2034, growing at a CAGR of 7.0% over the next six years.
In 2025, the global top five players—BASF, Evonik, Kerry, UPM Pharmaceuticals, and Colorcon—accounted for approximately 45% of total revenue. The report surveys manufacturers, suppliers, distributors, and industry experts, covering sales, revenue trends, price dynamics, product innovations, recent developments, drivers, challenges, and potential risks.
Recent breakthroughs in polymer science, fluidized‑bed and pan coating equipment, and digital process control have reshaped the landscape of pharmaceutical coating. The global Pharmaceutical Coating market was valued at US$10.3 billion in 2025 and is projected to reach US$15.8 billion by 2034, at a CAGR of 4.6% during the forecast period. These innovations enable thinner, more uniform films that improve dissolution, protect moisture‑sensitive APIs, and support complex release profiles. In the United States, the market size is estimated at US$2.1 billion in 2025, while China is on track to reach US$1.8 billion, reflecting strong demand from both mature and emerging drug pipelines. The tablets segment alone is expected to account for US$6.5 billion by 2034, growing at a compound annual rate of 5.2% over the next six years. Leading manufacturers such as BASF, Evonik, Kerry, UPM Pharmaceuticals, and Colorcon together held roughly 45% of global revenue in 2025, underscoring a concentrated competitive arena where scale, formulation expertise, and advanced coating lines are decisive advantages.
Personalized Medicine & Targeted Delivery
The surge in personalized medicine is prompting formulators to tailor coating solutions that address patient‑specific needs, such as taste‑masking for pediatric doses, rapid‑release for emergency therapies, and modified‑release for chronic conditions. This trend is driving demand for flexible coating platforms that can accommodate low‑dose, high‑potency APIs while maintaining precise layer thicknesses. Consequently, manufacturers are expanding their portfolios with functional excipients that enable selective permeability, enabling clinicians to fine‑tune drug release kinetics without redesigning the core tablet.
The industry is increasingly adopting continuous coating technologies and AI‑driven predictive models to boost efficiency, reduce waste, and ensure regulatory compliance. Continuous coating lines can process up to 50% more product per hour compared with traditional batch equipment, lowering energy consumption and minimizing solvent emissions. Moreover, sustainability initiatives are encouraging the use of bio‑based polymers and solvent‑free coating methods, aligning with stricter environmental regulations across Europe and North America. Suppliers and contract manufacturers are also investing in modular plants that allow rapid scale‑up for niche products, thereby addressing the “blue‑ocean” opportunities identified in the market analysis. As a result, the competitive landscape is evolving, with new entrants focusing on digitalization and green chemistry while established players leverage their extensive R&D pipelines and global distribution networks to retain market share.
North America currently holds the largest share of the global Pharmaceutical Coating market. The United States, with an estimated market size of US$ 2.6 billion in 2025, benefits from a highly regulated environment, extensive R&D activities, and the presence of leading chemical manufacturers such as BASF, Evonik, and Kerry. The region’s strong emphasis on advanced dosage forms—particularly film‑coated tablets for chronic disease therapies—drives demand for sophisticated coating technologies. Moreover, high adoption of continuous manufacturing lines and increasing investments in biologics‑compatible coating processes reinforce North America’s leadership.
Key Highlights:
Asia‑Pacific is forecast to register the fastest compound annual growth rate (CAGR) of approximately 8.1 % from 2026 to 2034. China, India, Japan and South Korea together account for more than 35 % of the projected market by 2034. The surge is fueled by expanding generic drug production, an increasing number of tablet‑centric formulations, and government incentives to modernize pharmaceutical manufacturing. Rapid urbanization and rising middle‑class consumption of oral solid dosage forms further amplify demand for high‑quality coating solutions.
Key Highlights:
How is advanced manufacturing infrastructure influencing regional demand for Pharmaceutical Coating?
The rollout of advanced manufacturing infrastructure—characterized by continuous processing, real‑time release testing, and Industry 4.0 digital integration—is reshaping regional demand patterns. In North America, smart factories equipped with process analytical technology (PAT) enable tighter coating thickness control, reducing batch failures and increasing productivity. Meanwhile, in Europe, the focus on sustainability drives adoption of solvent‑free and aqueous coating systems. In Asia‑Pacific, newly built high‑throughput coating lines are essential to meet the volume‑driven needs of generic manufacturers. These infrastructure upgrades collectively elevate the overall market demand for sophisticated coating technologies.
Key Highlights:
Beyond the United States and Germany, countries such as China, India, Japan, and Brazil are emerging as vital investment hubs. In China, the “Made in China 2025” initiative encourages modernization of pharmaceutical plants, attracting foreign coating technology firms. India’s “Pharma Vision 2020” aims to increase export‑oriented manufacturing capacity, prompting joint ventures in advanced coating lines. Japan continues to lead in high‑precision, film‑coating technologies for biotech products, while Brazil’s expanding domestic market and regulatory incentives make it attractive for coating equipment manufacturers.
Digital transformation initiatives—often described as “smart factories”—are accelerating the adoption of next‑generation coating technologies across all regions. In Europe, the European Medicines Agency (EMA) supports the implementation of digital twins for coating processes to improve scalability and regulatory compliance. North America’s focus on precision medicine drives the need for customized coating solutions that can be rapidly configured through cloud‑based platforms. In Asia‑Pacific, government‑sponsored Industry 4.0 programs facilitate the deployment of AI‑driven defect detection and predictive maintenance for coating lines. These smart initiatives enhance operational efficiency, reduce waste, and enable faster time‑to‑market for coated products.
Key Highlights:
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
-> Key players include BASF, Evonik, Kerry, UPM Pharmaceuticals, Colorcon, Pharma Excipients, Ideal Cures, EasyCoat, Neha Life Sciences Pvt. Ltd., Spraycel Coatings, among others.
-> Key growth drivers include rising demand for modified‑release tablets, growth of oral solid dosage forms, regulatory emphasis on patient compliance, and increasing investment in advanced coating technologies such as spray‑dry and fluidized‑bed coating.
-> North America holds the largest market share, while Asia‑Pacific is the fastest‑growing region, driven by rapid expansion in China and India.
-> Emerging trends include bio‑based and sustainable coating polymers, smart coatings with embedded sensors for real‑time monitoring, and AI‑driven process optimization for higher efficiency and lower waste.
